Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma

• Published in: Oncology research and treatment Vol. 46; no. 7-8; p. 320
• Main Authors: Artzenroth, Jule Cecilia, Tintelnot, Joseph, Haag, Georg Martin, Gökkurt, Eray, Steffens, Johann, Stein, Alexander
• Format: Journal Article
• Language: English
• Published: Switzerland 01.08.2023
• Subjects: Programmed cell death protein 1/L1 inhibitors; Esophagogastric adenocarcinoma; Poly-(ARD-Ribose) polymerase inhibitors

Esophagogastric adenocarcinoma (EGA) is one of the leading causes of cancer-related mortality worldwide. Therapeutic options are limited for patients with recurrent or metastatic disease. Targeted therapy may be a suitable treatment for selected patients, but its efficacy remains elusive. Here, a 52...